Can gingiva-derived MSCs (GMSCs) help preserve β-cell function in #Type1Diabetes (#T1DM)? A phase 1 trial links GMSC therapy to improved residual β-cell function, potentially through CD8+ T-cell exhaustion.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction
#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction
October 3, 2026 at 12:30 PM
Can gingiva-derived MSCs (GMSCs) help preserve β-cell function in #Type1Diabetes (#T1DM)? A phase 1 trial links GMSC therapy to improved residual β-cell function, potentially through CD8+ T-cell exhaustion.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction
#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction
#Article in #MedComm
#CCR2 Orchestrates Preferential #Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell-Derived Extracellular #Vesicles in Rheumatoid Arthritis doi.org/10.1002/mco2...
#chemotaxis #RheumatoidArthritis #RA #GMSCs #inflammation
#CCR2 Orchestrates Preferential #Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell-Derived Extracellular #Vesicles in Rheumatoid Arthritis doi.org/10.1002/mco2...
#chemotaxis #RheumatoidArthritis #RA #GMSCs #inflammation
CCR2 Orchestrates Preferential Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Rheumatoid Arthritis
CCR2 orchestrates preferential homing of GMSC-derived extracellularvesicles to inflamed joints in rheumatoid arthritis.
doi.org
January 9, 2026 at 3:52 AM
#Article in #MedComm
#CCR2 Orchestrates Preferential #Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell-Derived Extracellular #Vesicles in Rheumatoid Arthritis doi.org/10.1002/mco2...
#chemotaxis #RheumatoidArthritis #RA #GMSCs #inflammation
#CCR2 Orchestrates Preferential #Homing and Therapeutic Efficacy of Gingival Mesenchymal Stem Cell-Derived Extracellular #Vesicles in Rheumatoid Arthritis doi.org/10.1002/mco2...
#chemotaxis #RheumatoidArthritis #RA #GMSCs #inflammation